Teva evolves with acquisition of Cephalon

RSS Video:: 

Teva is looking to bolster its brand business, says David Amsellem, an analyst with Piper Jaffray, in this video interview with The Deal magazine about Teva's $6.8 billion purchase of Cephalon.

Syndicate content